Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Show simple item record MASK Grp Menditto, Enrica Costa, Elisio Midao, Luis Haahtela, Tari Toppila-Salmi, S. Kuitunen, M. Valovirta, E. 2020-05-31T02:17:01Z 2021-12-17T22:45:25Z 2019-04
dc.identifier.citation MASK Grp , Menditto , E , Costa , E , Midao , L , Haahtela , T , Toppila-Salmi , S , Kuitunen , M & Valovirta , E 2019 , ' Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study ' , Clinical and Experimental Allergy , vol. 49 , no. 4 , pp. 442-460 .
dc.identifier.other PURE: 124495226
dc.identifier.other PURE UUID: bd447761-ff84-4fbc-9e48-0681966f9f23
dc.identifier.other WOS: 000463761700007
dc.identifier.other ORCID: /0000-0003-0890-6686/work/57307699
dc.description.abstract Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12143 users were registered. A total of 6949 users reported at least one VAS data recording. Among them, 1887 users reported >= 7 VAS data. About 1195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR >= 70% and PDC = 70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting. en
dc.format.extent 19
dc.language.iso eng
dc.relation.ispartof Clinical and Experimental Allergy
dc.rights.uri info:eu-repo/semantics/openAccess
dc.subject adherence
dc.subject mHealth
dc.subject mobile technology
dc.subject observational study
dc.subject rhinitis
dc.subject treatment
dc.subject K-ANONYMITY
dc.subject ASTHMA
dc.subject PERSISTENCE
dc.subject VALIDATION
dc.subject THERAPY
dc.subject DISEASE
dc.subject TRIAL
dc.subject 3121 General medicine, internal medicine and other clinical medicine
dc.title Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study en
dc.type Article
dc.contributor.organization Department of Dermatology, Allergology and Venereology
dc.contributor.organization University of Helsinki
dc.contributor.organization Clinicum
dc.contributor.organization Children's Hospital
dc.contributor.organization HUS Children and Adolescents
dc.contributor.organization HUS Inflammation Center
dc.description.reviewstatus Peer reviewed
dc.relation.issn 0954-7894
dc.rights.accesslevel openAccess
dc.type.version acceptedVersion

Files in this item

Total number of downloads: Loading...

Files Size Format View
Menditto_et_al_ ... 6_Experimental_Allergy.pdf 966.7Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record